Prevalence of tobacco use among cancer patients in Iran: a systematic review and meta-analysis

BMC Public Health

Table 3 The sensitivity analysis after removed outlier studies

Analysis	Proportion	95%CI	95%PI	I²	95%CI
Main Analysis	0.43	0.35–0.52	0.1–0.84	0.98	0.98–0.98
Infl. Cases Removed with dmetar^a	0.41	0.37–0.46	0.27–0.57	0.73	0.57–0.83
Infl. Cases Removed with GOSH^b	0.43	0.35–0.51	0.12–0.81	0.97	0.96–0.97

^aRemoved as outliers: Abdolahinia et al. (2021) [30], Aminisani et al. (2016) [40], Hadji et al. (2021) [36], Hosseini et al. (2022) [38], Khoshbaten et al. (2010) [44], Mafi et al. (2012) [45], Mashhadi et al. (2011) [47], Masjedi et al. (2013) [48], Moghadam et al. (2021) [33], Mohebbi et al. (2020) [49], Momayez et al. (2021) [50], Momtahen et al. (2009) [37], Pournaghi et al. (2018) [54], Saedi et al. (2009) [56], Sheikh et al. (2020) [58], Simonian et al. (2018) [60], Tarrahi et al. (2009) [62]
^bRemoved as outliers: Hadji et al. (2021) [36], Mashhadi et al. (2011) [47], Masjedi et al. (2013) [48], Momtahen et al. (2009) [37], Motovali-bashi et al. (2012) [51], Sheikh et al. (2020) [62]

ISSN: 1471-2458